On October 25, 2023, a group of auditors of "VALARTIN PHARMA" LLC conducted an audit in the laboratory.

The purpose of the audit was to confirm the performance of work on the quality control of raw materials and finished medicinal products according to physico-chemical, biochemical and microbiological indicators in compliance with the requirements of DSTU EN ISO/IEC 17025:2017.